EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study

Abby Ostronic, Christine Gremillion, Song Zhang, Joerg M Steiner iD, M Katherine Tolbert iD, Emily N Gould iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Abby Ostronic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M University, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, Coll…. Hauptthemen laut MEDLINE: Esomeprazole, Cross-Over Studies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esomeprazole use is increasing in dogs, but the gastrointestinal adverse events associated with q12h dosing necessitate pharmacodynamic evaluation of a reduced dose and frequency of administration.

Objectives

To compare the efficacy of 2 doses of (q24h) esomeprazole in raising intragastric pH in dogs. Animals Nine healthy, client-owned dogs, >20 kg.

Methods

Prospective, randomized, double blinded, crossover study. Esomeprazole (0.5 or 1 mg/kg q24h) was orally administered for up to 5 days per treatment arm, and the mean percentage time intragastric pH was ≥3 (MPT3) and ≥4 (MPT4) for 24 hours periods were compared to pretreatment pH using a continuous pH monitoring system. Dogs failing to reach pH goals (MPT3 ≥75%, MPT4 ≥66%) with once daily dosing received esomeprazole 1 mg/kg PO q12h to determine if a higher dose would improve acid suppression.

Results

No significant difference in the MPT3 or MPT4 was identified between treatments for any time point (P > .05). Both doses increased the MPT pH ≥3 and 4 median [range] (0.5 mg/kg, 1 mg/kg) on days 1 (MPT3: 76.8% [44-100], 69.2% [28.2-100]; MPT4: 65.6% [16.7-99.3], 54.9% [14.9-93.3]; P = .0009) and 2 (MPT3:77.2% [27.4-100], 75.4% [49.4-89.5]; MPT4: 66.3% [15.5-100], 59.7% [33.8-81.2]; P = .0005) of PPI treatment compared to pretreatment (MPT3: 58.3% [0.02-93.9], 52.6% [6.1-94.7]; MPT4: 25.2% [0-86.8], 32.4% [1.8-89.3]). Six dogs (66%, [0.36, 0.97]) reached pH goals established in humans with q24h dosing. Conclusions and Clinical Importance Both q24h PO esomeprazole doses were effective in raising intragastric pH, despite high intersubject variability, but 33% of dogs required q12h dosing to reach pH goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EsomeprazoleCross-Over StudiesAnimalsDogsMaleHydrogen-Ion ConcentrationFemaleProspective StudiesAdministration, OralDouble-Blind MethodAnti-Ulcer AgentsDose-Response Relationship, DrugProton Pump Inhibitors

Stichwörter der Autor:innen

Nexiumacid suppressantintragastric pHproton pump inhibitor

Substanzen

EsomeprazoleAnti-Ulcer AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Texas A&M University, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
  • Texas A&M University, Department of Large Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
  • Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.

ORCID-Profile: Joerg M Steiner, M Katherine Tolbert, Emily N Gould

Zitieren

APA

Ostronic, A., Gremillion, C., Zhang, S., Steiner, J. M., Tolbert, M. K., & Gould, E. N. (2024). Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17233

Vancouver

Ostronic A, Gremillion C, Zhang S, Steiner JM, Tolbert MK, Gould EN. Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17233

BibTeX
@article{Ostronic2024,
  author = {Ostronic, Abby and Gremillion, Christine and Zhang, Song and Steiner, Joerg M and Tolbert, M Katherine and Gould, Emily N},
  title = {Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17233}
}
Kostenlos starten →